K. Angela Macfarlane - 26 Jan 2024 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role: Director
Signature: /s/ K Angenla MacFarlane
Issuer symbol: RNXT
Transactions as of: 26 Jan 2024
Net transactions value: $0
Form type: 4
Filing time: 30 Jan 2024, 18:30:25 UTC
Previous filing: 02 Oct 2023
Next filing: 02 Oct 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RNXT	Common Stock	Purchase		+40,983			40,983	26 Jan 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RNXT	Warrant Shares	Purchase		+40,983			40,983	26 Jan 2024	Common Stock	40,983	$1.22	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029.

Content

Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029.